CaNIOS Information

CaNIOS is a public-private partnership, and receives peer-reviewed funding from the Canadian Institutes of Health Research (CIHR) as well as funding from both private benefactors and not-for-profit organizations. CaNIOS is aiming to expand its infrastructure, while its members from different institutions strive to submit new grants to peer-reviewed funding agencies. These grants would cover the direct cost of performing investigator-driven research studies. However, the overall cost of maintaining an infrastructure such as that required by CaNIOS exceeds what can be obtained through peer-reviewed funding. CaNIOS has matured over the past 17 years. As new potential treatments are becoming available for consumers with lupus, it remains a challenge to understand this disease well and to diagnose appropriately and early those that would benefit from early and better treatments.